Lebanon, NH – May 1, 2026 – Bio X Cell, the global leader in functional, in vivo-ready antibody solutions for translational research, today announced a new distribution partnership with Shandong Haosaitechnology Co., Ltd, strengthening access to high-performance research reagents across the Shandong Province, China.
Founded in 2008, Shandong Haosaitechnology Co., Ltd has established itself as a trusted scientific solutions provider, delivering a comprehensive portfolio spanning instruments, biological reagents, and experimental services. With integrated capabilities across technology R&D, technical design, and platform management, Shandong Haosaitechnology Co., Ltd supports researchers through the full lifecycle of their work, from early-stage technical guidance to post-sales support. Its regional footprint across Qingdao, Jinan, and Yantai enables responsive, localized service for a broad and growing scientific community.
This partnership reflects Bio X Cell’s continued investment in enabling reproducible, high-quality research at a regional level. Through Shandong Haosaitechnology Co., Ltd, researchers across Shandong Province will gain streamlined access to Bio X Cell’s portfolio of ultra-pure, low-endotoxin functional antibodies, engineered specifically for reliable performance in sensitive in vivo studies and advanced in vitro systems, including organoids and organ-on-chip models.
By combining Shandong Haosaitechnology Co., Ltd's technical infrastructure and regional expertise with Bio X Cell’s globally trusted antibody platform, the collaboration is designed to reduce procurement friction while increasing experimental confidence. Researchers will benefit from consistent access to antibodies manufactured to ≥95% purity, with endotoxin levels as low as ≤0.5 EU/mg, eliminating common sources of variability such as cytokine artifacts and off-target immune activation. Supported by nearly 30,000 peer-reviewed citations, Bio X Cell antibodies provide a reproducible foundation for immunology, oncology, and translational research workflows.
“Expanding our presence in China through strong regional partners is a critical part of our global strategy,” said Christopher Conway, CEO of Bio X Cell. “Shandong Haosaitechnology Co., Ltd brings a powerful combination of technical expertise, operational excellence, and customer-first values. Together, we are enabling researchers to access functional antibodies designed not just for binding, but for performance in complex biological systems.”
With this partnership, Bio X Cell continues to advance its mission of delivering functional antibodies that maintain consistency across murine, organoid, and human-relevant systems, supporting researchers as they move from discovery through translational validation with confidence.
Researchers in Shandong Province can now access Bio X Cell products directly through Shandong Haosaitechnology Co., Ltd. For inquiries or to request a quote, please contact:
Shandong Haosaitechnology Co., Ltd
Floor 4, Building 10, Jinan Biomedical Seience and Technology Park,
No. 30766, Jingshi East Road, Jinan, Shandong, China
Tel: 400-6947-688
About Bio X Cell
Bio X Cell is the global leader of in vivo-ready antibodies, delivering consistent, high-purity, low-endotoxin antibody solutions to scientists worldwide. Cited in nearly 30,000 peer-reviewed publications, Bio X Cell antibodies drive discovery in cancer, immunology, immuno-oncology, neuroscience, and infectious disease. Allowing experiments to seamlessly scale from milligrams to grams, researchers can confidently progress from discovery through translational studies without switching suppliers or compromising quality. Catalog products are always in stock, and custom services offer an industry-leading 4-week turnaround time. Bio X Cell is headquartered in the US and has regional distribution and logistics hubs in Germany and China. Bio X Cell partners with over 30 distributors to enable the shipping of antibody workflow solutions globally. By supporting every stage of the research workflow, Bio X Cell enables innovation that positively impacts patients and families across the world.